© 2022 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

Science News

Antibodies attacking COVID-19
Monoclonal Antibody Combo Authorized for COVID-19 PrEP
Pfizer Paxlovid COVID-19
FDA Authorizes First Antiviral Pill for COVID-19
Rhesus macaque
Intranasal COVID-19 Vaccine Effective in Animal Studies
SARS-CoV-2 virus particles within the endosomes of a nasal olfactory epithelial cell

SARS-CoV-2 Antigen Levels Linked to Patient Outcomes

Higher levels of viral antigens in the blood correlated with more severe disease.

New COVID-19 Boosters Target Current Coronavirus Variants

Updated Pfizer-BioNTech and Moderna bivalent boosters contain spike proteins from the original and BA.4 and BA.5 omicron variants.

Fighting Current and Future Coronaviruses With a Single Vaccine

An experimental vaccine produced an immune response to a range of different coronaviruses in mice and monkeys, including SARS-CoV-2.

FDA and CDC Give Green Light to Novavax COVID-19 Vaccine

The engineered protein vaccine was highly effective in a clinical trial but faced a long delay for authorization.

Tracking SARS-CoV-2 Coronavirus Variants in Wastewater

Using wastewater to track the emergence of new variants of concern could be faster and less expensive than clinical testing.
Novel coronavirus SARS-CoV-2

Vaccine-Induced Immune Response to Omicron Wanes Substantially Over Time

Antibody levels decrease substantially within three months after a booster, according to new clinical trial data.
SARS-CoV-2, the coronavirus that causes COVID-19

Interferon Treatment May Reduce Severity of COVID-19 in People With Certain Genetic Factors

People of European or African ancestry who were hospitalized for COVID-19 are more likely to carry particular genetic variants.

Immune Response Triggered by COVID-19 May Damage the Brain

Findings from small NIH study could provide insight into long-term neurological symptoms of COVID-19.

Long COVID Symptoms Linked to Inflammation

Prolonged inflammation after SARS-CoV-2 infection caused permanent organ damage, affected the brain and correlated with behavioral changes.
Novel coronavirus SARS-CoV-2

Immune Modulator Drugs Improved Survival for People Hospitalized With COVID-19

Two drugs widely used to treat certain autoimmune diseases substantially improved clinical status and reduced deaths.

Youngest Kids Can Finally Get COVID Vaccines

After a long wait, the FDA authorizes Pfizer and Moderna vaccines for children as young as 6 months old.
Monkeypox virus

Monkeypox Is Not Airborne, CDC Says

The virus can be transmitted via respiratory droplets at close range, but it does not spread through the air over longer distances.

Telehealth for Cancer Care Increased During COVID-19 Pandemic

However, Black people and uninsured folks with cancer were not as likely to access care via telemedicine.

T Cells Protect Against COVID-19 in Absence of Antibody Response

Vaccines designed to produce a strong T cell response may help protect against current and future SARS-CoV-2 variants.

Are People With HIV at Greater Risk for COVID-19 Breakthrough?

The good news is that only 4% of HIV-positive people experienced COVID breakthrough after vaccination.
SARS-CoV-2, the coronavirus that causes COVID-19

Food Allergy Associated with Lower Risk of SARS-CoV-2 Infection

NIH study finds high BMI and obesity raise infection risk, but asthma does not.
Advertisement
Features
Newsfeed

Hot topics

face masks
Face Masks
a US dollar symbol in a life preserver
Health Equity

COVID Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy

Manage

COVID Health uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.